Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Pan-cancer patterns of somatic copy number alteration
2013
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
2015
First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
2013
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials
2014
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
1998
The biology and management of non-small cell lung cancer
2018 StandoutNature
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Lung Cancer
2008 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
2012
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism
1989 StandoutNature
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Angiogenesis in life, disease and medicine
2005 StandoutNature
Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer
1991
A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens
1988
The microenvironment of the tumour–host interface
2001 StandoutNature
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
2013
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a canadian multicenter randomized trial
1988
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)
2010
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
2009
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
2005
Small cell lung cancer: the importance of the extracellular matrix
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Gefitinib for non-small-cell lung cancer treatment
2011
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
2010
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Symptom Frequency and Severity in Patients with Metastatic or Locally Recurrent Lung Cancer: A Prospective Study Using the Lung Cancer Symptom Scale in a Community Hospital
2001
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 StandoutNatureNobel
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 StandoutScience
Mechanism of activation of adenylate cyclase byVibrio cholerae enterotoxin
1975
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The landscape of metastatic progression patterns across major human cancers
2014
T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes
1982 StandoutNatureNobel
Evidence that translocation of the glucose transport activity is the major mechanism of insulin action on glucose transport in fat cells.
1982
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
1985
Energy-dependent and protein synthesis-independent recycling of the insulin-sensitive glucose transport mechanism in fat cells.
1981
beta-Adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes.
1983
Regulation of transmembrane signaling by receptor phosphorylation
1987 StandoutNobel
Proposed mechanism of insulin-resistant glucose transport in the isolated guinea pig adipocyte. Small intracellular pool of glucose transporters.
1983 StandoutNobel
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
The role of hormone receptors and GTP-regulatory proteins in membrane transduction
1980 StandoutNatureNobel
The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins.
1986 StandoutNobel
Reversible activation of hepatic adenylate cyclase by guanyl-5'-yl-(alpha,beta-methylene)diphosphonate and guanyl-5'-yl imidodiphosphate.
1977 StandoutNobel
Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)
2014
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
2011
Partial purification of the D-glucose transport system in rat adipocyte plasma membranes.
1977
Uptake and degradation of 125I-labelled asialo-fetuin by isolated rat hepatocytes
1977
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
2014
The Insulin-Sensitive Glucose Transporter
1992
Mechanism of insulin action on glucose transport in the isolated rat adipose cell. Enhancement of the number of functional transport systems.
1978
Fractionation of endocytic vesicles and glucose-transporter-containing vesicles in rat adipocytes
1988
Ultrastructural localization of insulin receptors on adipocytes.
1975
Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer
1999
Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study
2013
Membrane-permeant Esters of Phosphatidylinositol 3,4,5-Trisphosphate
1998 StandoutNobel
Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding.
1976 StandoutNobel
DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc.
1989 StandoutNobel
Uptake and degdradation of formaldehyde-treated 125I-labeled human serum albumin in rat liver cells in vivo and in vitro
1977
Secretin Promotes Osmotic Water Transport in Rat Cholangiocytes by Increasing Aquaporin-1 Water Channels in Plasma Membrane
1997 StandoutNobel
Actions of insulin in fat cells. Effects of low temperature, uncouplers of oxidative phosphorylation, and respiratory inhibitors.
1977
Binding and receptor-mediated degradation of insulin in adipocytes
1978
Systematic reviews of trials and other studies.
1998
The Role of Calcium in Insulin Action
1975
Metabolic reprogramming and cancer progression
2020 StandoutScience
Potential mechanism of insulin action on glucose transport in the isolated rat diaphragm. Apparent translocation of intracellular transport units to the plasma membrane.
1981
Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.
1986 StandoutNobel
Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.
1982 StandoutNobel
The effect of insulin on the washout of [45Ca]calcium from adipocytes and soleus muscle of the rat
1977
Is an early calcium flux necessary to stimulate lymphocytes?
1977 Nature
Mechanism of Insulin-resistant Glucose Transport Activity in the Enlarged Adipose Cell of the Aged, Obese Rat
1982
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Irreversible stimulation of adenylate cyclase activity of fat cell membranes by phosphoramidate and phosphonate analogs of GTP
1975
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior.
1985
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.
1980
β-adrenoceptor studies. 6. Further investigations on the hybrid nature of the rat adipocyte β-adrenoceptor
1980
Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. The role of protein phosphatase 2a in attenuation of the signal.
1990 StandoutNobel
Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes
1999
Activation of adenylate cyclase in hepatic membranes involves interactions of the catalytic unit with multimeric complexes of regulatory proteins.
1979 StandoutNobel
Binding of 125I-labeled glucagon and glucagon-stimulated accumulation of adenosine 3‘:5‘-monophosphate in isolated intact rat hepatocytes. Evidence for receptor heterogeneity.
1978
Etoposide (VP-16–213)
1985
Insulin and glucose 6-phosphate stimulation of Ca2+ uptake by skinned muscle fibers.
1980 StandoutNobel
Molecular Characterization of the Human β 3 -Adrenergic Receptor
1989 StandoutScience
Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer
1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
1987
Oncogene Amplification in Tumor Cells
1986
Relationship between the beta-adrenergic receptor and adenylate cyclase.
1977 StandoutNobel
Resolution of beta-adrenergic receptor binding and adenylate cyclase activity by gel exclusion chromatography.
1977 StandoutNobel
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.
1994
The properties and extracellular location of 5′-nucleotidase of the rat fat-cell plasma membrane
1975
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 StandoutNobel
Isoproterenol stimulates shift of G proteins from plasma membrane to pinocytotic vesicles in rat adipocytes: a possible means of signal dissemination.
1990 StandoutNobel
Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane.
1980
Fluid‐phase endocytosis by isolated rat adipocytes
1984
Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.
1975
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
1987
Co-translational membrane integration of calcium pump protein without signal sequence cleavage
1981 StandoutNatureNobel
Works of Kell Østerlind being referenced
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
2008
Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients.
1985
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.
1994
The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization. A study of 375 consecutive patients
1983
Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung
1985
Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation
1987
Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
1986
Exchange of 3-O-methylglucose in isolated fat cells. Concentration dependence and effect of insulin.
1976
Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients.
1987
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up
1986
Staging and prognostic factors in small cell carcinoma of the lung.
1983
A rapid technique for separation of thymocytes from suspensions by centrifugation through silicone oil
1974
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.
1983
A procedure for measurement of distribution spaces in isolated fat cells
1972
Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.
1986
Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and posttreatment specimens in 104 patients
1986
Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma
1994
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
1992
Influence of surgical resection prior to chemotherapy on the long-term results in small cell lung cancer. A study of 150 operable patients
1986
Phase II study of teniposide in small cell carcinoma of the lung.
1984